We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

SPINREACT S.A.

SPINREACT develops and manufactures in vitro clinical diagnostic reagents in the areas of clinical chemistry, serolog... read more Featured Products: More products

Download Mobile App





Spinreact Presents Latest Developments in IVD

By LabMedica International staff writers
Posted on 07 Feb 2024
Print article
Image: The latest developments in IVD showcased at Medlab Middle East 2024 (Photo courtesy of Spinreact)
Image: The latest developments in IVD showcased at Medlab Middle East 2024 (Photo courtesy of Spinreact)

Spinreact (Girona, Spain) is presenting its latest developments in IVD at Medlab Middle East in Dubai, taking place February 5-8, 2024.

At Medlab Middle East 2024, Spinreact is showcasing the Spin XS fully automated clinical chemistry analyzer that allows labs to automate tests quickly and cost-effectively. The compact and economical instrument saves space, making it perfect for small and medium-sized laboratories. Spinreact is also highlighting the e-Spin10, an affordable, fast, and accurate electrolyte analyzer that can measure the concentration of up to 7 parameters: Na+, K+, Cl-, Ca2+, pH, Li+, TCO2 in whole blood, serum, plasma, and urine samples. It has a 7-inch touch screen, integrated printer, and optional automatic sample loader.

Among other products showcased at the event is the Spin 640 Plus clinical chemistry analyzer, which is a fully automated, high-volume tester perfectly suited to the needs of a large laboratory. The equipment has an automatic washing system with 8 stages, an internal barcode reader (optional), and coagulation detection of the samples. Spinreact is highlighting the Spincell 3n 3-part hematology analyzer that is designed to provide more confidence in the results and less response time to laboratories around the world. In addition to its compact size, it offers measurement of 22 parameters and three histograms, an HD touch screen, and a throughput of 72 samples per hour. The Spincell 3n is easy to use and economical and offers accurate results.

Visitors to the Spinreact booth at Medlab Middle East 2024 can also experience the Spinlab S semi-automatic chemical analyzer which features a large 7-inch color touch screen. Featuring a high-precision optical system with eight wavelengths, the Spinlab S offers both flowcell and disposable cuvette modes. Also featured at the show are the BIOBAS 10 single-channel coagulation analyzer with a micro-processor for programming parameters and making calculations, alongside the BIOBAS 20/40 coagulometers with two/four channels that are easy to use with programmable parameters and calculation of results.

Related Links:
Spinreact

New
Platinum Member
Flu SARS-CoV-2 Combo Test
OSOM® Flu SARS-CoV-2 Combo Test
Magnetic Bead Separation Modules
MAG and HEATMAG
POCT Fluorescent Immunoassay Analyzer
FIA Go
Gold Member
Fully Automated Cell Density/Viability Analyzer
BioProfile FAST CDV

Print article
77 ELEKTRONIKA

Channels

Clinical Chemistry

view channel
Image: PhD student and first author Tarek Eissa has analyzed thousands of molecular fingerprints (Photo courtesy of Thorsten Naeser / MPQ / Attoworld)

Screening Tool Detects Multiple Health Conditions from Single Blood Drop

Infrared spectroscopy, a method using infrared light to study the molecular composition of substances, has been a foundational tool in chemistry for decades, functioning similarly to a molecular fingerprinting... Read more

Molecular Diagnostics

view channel
Image: Researchers have found the first evidence of testing for the alpha-synuclein protein in blood samples via seed amplification assay (Photo courtesy of Shutterstock)

Blood Test to Detect Alpha-Synuclein Protein Could Revolutionize Parkinson's Disease Diagnostics

Currently, Parkinson's disease (PD) is identified through clinical diagnosis, typically at a later stage in the disease's progression. There is a pressing need for an objective and quantifiable biomarker... Read more

Hematology

view channel
Image: The Truvian diagnostic platform combines clinical chemistry, immunoassay and hematology testing in a single run (Photo courtesy of Truvian Health)

Automated Benchtop System to Bring Blood Testing To Anyone, Anywhere

Almost all medical decisions are dependent upon laboratory test results, which are essential for disease prevention and the management of chronic illnesses. However, routine blood testing remains limited worldwide.... Read more

Immunology

view channel
Image: The blood test measures lymphocytes  to guide the use of multiple myeloma immunotherapy (Photo courtesy of 123RF)

Simple Blood Test Identifies Multiple Myeloma Patients Likely to Benefit from CAR-T Immunotherapy

Multiple myeloma, a type of blood cancer originating from plasma cells in the bone marrow, sees almost all patients experiencing a relapse at some stage. This means that the cancer returns even after initially... Read more

Microbiology

view channel
Image: Ultra-Rapid Antimicrobial Susceptibility Testing (uRAST) revolutionizing traditional antibiotic susceptibility testing (Photo courtesy of Seoul National University)

Ultra-Rapid Culture-Free Sepsis Test Reduces Testing Time from Days to Hours

Sepsis, a critical emergency condition, results from an overactive inflammatory response to pathogens like bacteria or fungi in the blood, leading to organ damage and the possibility of sudden death.... Read more

Pathology

view channel
Image: The AI model can distinguish different stages of DCIS from inexpensive and readily available breast tissue images (Photo courtesy of David A. Litman/Shutterstock)

AI Model Identifies Breast Tumor Stages Likely To Progress to Invasive Cancer

Ductal carcinoma in situ (DCIS) is a non-invasive type of tumor that can sometimes progress to a more lethal form of breast cancer and represents about 25% of all breast cancer cases. Between 30% and 50%... Read more

Industry

view channel
Image: Beckman Coulter will utilize the ALZpath pTau217 antibody to detect key biomarker for Alzheimer\'s disease on its DxI 9000 immunoassay analyzer (Photo courtesy of Beckman Coulter)

Beckman Coulter Licenses Alzpath's Proprietary P-tau 217 Antibody to Develop Alzheimer's Blood Test

Cognitive assessments have traditionally been the primary method for diagnosing Alzheimer’s disease, but this approach has its limitations as symptoms become apparent only after significant brain changes... Read more
MEDLAB 2024
Copyright © 2000-2024 Globetech Media. All rights reserved.